EDINBURGH-based Aquila BioMedical has been acquired by drug discovery and development group Concept Life Sciences.
Aquila was spun-out of the University of Edinburgh in 2011. It is a pre-clinical contract research organisation with expertise in immuno-oncology, immunology and multiplex histology
Manchester-based Concept said the acquisition, for an undisclosed amount, is a pivotal addition to the comprehensive range of services it provides.
Aquila has developed a way to help its customers better understand the cellular and molecular events that occur with compound administration of certain drugs. Its technology allows researchers to improve the success rates of drug effectiveness, and reduce the overall cost associated with drug development.
Last year, Aquila had retained earnings of £324,225.
Michael Fort, executive chairman, Concept Life Sciences, said: “We are excited to add Aquila to the Concept group. Both Aquila and Concept have been built around the same value of working closely with customers to tailor services according to the project objectives, and together we will provide high quality, integrated solutions.”
Professor Jonathan Seckl, vice principal of planning, resources and research policy at the University, said: “We congratulate the Aquila team on this milestone in their approach to building advanced biology into innovative drug discovery. This investment highlights the University’s commitment to successfully translating our world-class research into practical application by industry.”
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here